Nodin N, Carballo-Diéguez A, Ventuneac A M, Balan I C, Remien R
HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY 10032, USA.
AIDS Care. 2008 Jan;20(1):106-15. doi: 10.1080/09540120701449096.
Condom use is the best available strategy to prevent HIV infection during sexual intercourse. However, since many people choose not to use condoms in circumstances in which HIV risk exists, alternatives to condom use for HIV prevention are needed. Currently there are several alternative bio-medical HIV-prevention products in different stages of development: microbicides, vaccines, post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). Seventy-two men who have sex with men (MSM) who took part in a study on Internet use and intentional condomless anal intercourse were asked about these four products during a semi-structured interview. The questions explored knowledge and acceptability of all the products and willingness to participate in microbicide and vaccine trials. Qualitative analysis of the data suggests that these men had virtually no knowledge of PrEP, very limited knowledge of microbicides, some information about PEP and considerably more knowledge about vaccines. Reactions towards the products were generally positive except for PrEP, for which reactions were polarized as either enthusiastic or negative. With the exception of PrEP, many men expressed willingness to use the products in the future. Most men would be willing to participate in trials for microbicides and vaccines if given basic reassurances. Concerns over negative side effects and preoccupation with possible infection were some of the motives given for non-willingness to participate in a vaccine trial. These results should inform the development of future trials of biomedical prevention products.
使用避孕套是在性交过程中预防艾滋病毒感染的最佳可行策略。然而,由于许多人在存在感染艾滋病毒风险的情况下选择不使用避孕套,因此需要有替代避孕套的艾滋病毒预防方法。目前有几种处于不同研发阶段的替代生物医学艾滋病毒预防产品:杀微生物剂、疫苗、暴露后预防(PEP)和暴露前预防(PrEP)。在一项关于互联网使用和故意无保护肛交的研究中,72名男男性行为者(MSM)在半结构化访谈中被问及这四种产品。这些问题探讨了所有产品的知识和可接受性,以及参与杀微生物剂和疫苗试验的意愿。对数据的定性分析表明,这些男性对PrEP几乎一无所知,对杀微生物剂的了解非常有限,对PEP有一些了解,对疫苗的了解则多得多。除了PrEP,对这些产品的反应总体上是积极的,而对PrEP的反应则两极分化,要么热情要么消极。除了PrEP,许多男性表示愿意在未来使用这些产品。如果得到基本的保证,大多数男性愿意参加杀微生物剂和疫苗试验。对负面副作用的担忧以及对可能感染的担忧是一些人不愿意参加疫苗试验的动机。这些结果应为未来生物医学预防产品试验的开展提供参考。